Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
Titel:
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
Auteur:
Tannock, Ian F Fizazi, Karim Ivanov, Sergey Karlsson, Camilla Thellenberg Fléchon, Aude Skoneczna, Iwona Orlandi, Francisco Gravis, Gwenaelle Matveev, Vsevolod Bavbek, Sevil Gil, Thierry Viana, Luciano Arén, Osvaldo Karyakin, Oleg Elliott, Tony Birtle, Alison Magherini, Emmanuelle Hatteville, Laurence Petrylak, Daniel Tombal, Bertrand Rosenthal, Mark